Neo-Adjuvant Chemo/Immunotherapy in the Treatment of Stage III (N2) Non-Small Cell Lung Cancer: A Phase I/Ii Pilot Study
International Journal of Immunopathology and Pharmacology - Italy
doi 10.1177/039463201102400418
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2011
Authors
Publisher
SAGE Publications